576: Patient Randomization Factors in the P53 Targeted Therapy Trial in Bladder Cancer (SWOG 4B951)

Journal article

Peer reviewed

Ellenie D Tuazon, Susan G Groshen, Seth P Lerner, Walter Stadler, John P Stein and Richard J Cote

The Journal of urology, Vol.177(4S), pp.192-192

2007-04

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.233 Pelvic & Renal Disorders; 1.233.690 Bladder Cancer
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 576: Patient Randomization Factors in the P53 Targeted Therapy Trial in Bladder Cancer (SWOG 4B951)
Creators: Ellenie D Tuazon
Susan G Groshen
Seth P Lerner
Walter Stadler
John P Stein
Richard J Cote
Publication Details: The Journal of urology, Vol.177(4S), pp.192-192
Academic Unit: Miller School of Medicine; UMMG Department of Pathology
Language: English
Resource Type: Journal article
Record Identifier: 991031598128402976